{
    "organizations": [],
    "uuid": "83cb3492bf9c45dc0c2c92009bc4a316fa4b4e54",
    "author": "",
    "url": "https://www.reuters.com/article/brief-revive-therapeutics-and-ehave-ente/brief-revive-therapeutics-and-ehave-enter-into-patient-research-data-collaboration-agreement-idUSFWN1QJ0ST",
    "ord_in_thread": 0,
    "title": "BRIEF-Revive Therapeutics And Ehave Enter Into Patient Research Data Collaboration Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1, 2018 / 12:12 PM / in 7 minutes BRIEF-Revive Therapeutics And Ehave Enter Into Patient Research Data Collaboration Agreement Reuters Staff 1 Min Read March 1 (Reuters) - Ehave Inc: * REVIVE THERAPEUTICS AND EHAVE ENTER INTO PATIENT RESEARCH DATA COLLABORATION AGREEMENT FOR MEDICAL CANNABIS LIVER DISEASE PROGRAM Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)",
    "published": "2018-03-01T14:10:00.000+02:00",
    "crawled": "2018-03-01T14:25:44.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "minute",
        "therapeutic",
        "ehave",
        "enter",
        "patient",
        "research",
        "data",
        "collaboration",
        "agreement",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "ehave",
        "inc",
        "revive",
        "therapeutic",
        "ehave",
        "enter",
        "patient",
        "research",
        "data",
        "collaboration",
        "agreement",
        "medical",
        "cannabis",
        "liver",
        "disease",
        "program",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}